FCQAX
Price
$9.75
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
3.3B
FCTFX
Price
$12.35
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
1.87B
Interact to see
Advertisement

FCQAX vs FCTFX

Header iconFCQAX vs FCTFX Comparison
Open Charts FCQAX vs FCTFXBanner chart's image
FCQAX vs FCTFX Comparison Chart in %
View a ticker or compare two or three
VS
FCQAX vs. FCTFX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCQAX is a Hold and FCTFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FCQAX has more cash in the bank: 3.3B vs. FCTFX (1.87B). FCQAX pays higher dividends than FCTFX: FCQAX (4.16) vs FCTFX (3.03). FCQAX was incepted earlier than FCTFX: FCQAX (8 years) vs FCTFX (42 years). FCQAX (0.80) is less costly to investors than FCTFX (0.43). FCTFX is a more actively managed with annual turnover of: 19.00 vs. FCQAX (13.89). FCTFX has a lower initial minimum investment than FCQAX: FCTFX (0) vs FCQAX (1000). FCQAX annual gain was more profitable for investors over the last year : 7.27 vs. FCTFX (6.91). FCTFX return over 5 years is better than : 4.78 vs. FCQAX (-1.69).
FCQAXFCTFXFCQAX / FCTFX
Total Expense Ratio0.800.43186%
Annual Report Gross Expense Ratio0.800.43186%
Fund Existence8 years42 years-
Gain YTD1.9461.183164%
Front Load4%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.3B1.87B176%
Annual Yield % from dividends4.163.03137%
Returns for 1 year7.276.91105%
Returns for 3 years12.9412.78101%
Returns for 5 years-1.694.78-35%
Returns for 10 yearsN/A21.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDR36.391.88
+5.45%
Idaho Strategic Resources
BR144.870.99
+0.68%
Broadridge Financial Solutions
GLMD0.61N/A
-0.63%
Galmed Pharmaceuticals Ltd
FSLY18.55-0.33
-1.75%
Fastly
ONCY0.80-0.02
-2.07%
Oncolytics Biotech